GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LABP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Stronger technical forecast for Landos Biopharma, Inc. stock price after Wednesday trading.
(Updated on Apr 17, 2024)

Buy or Hold candidate since Jan 02, 2024 Gain 401.62% PDF

The Landos Biopharma, Inc. stock price gained 0.697% on the last trading day (Wednesday, 17th Apr 2024), rising from $21.52 to $21.67. During the last trading day the stock fluctuated 1.12% from a day low at $21.46 to a day high of $21.70. The price has risen in 6 of the last 10 days and is up by 0.84% over the past 2 weeks. Volume fell on the last day by -4 thousand shares and in total, 15 thousand shares were bought and sold for approximately $331.05 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 500.56% during the next 3 months and, with a 90% probability hold a price between $101.23 and $141.69 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LABP Signals & Forecast

The Landos Biopharma, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $21.55 and $13.88. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, January 24, 2024, and so far it has risen 376.26%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Landos Biopharma, Inc. stock

Landos Biopharma, Inc. finds support from accumulated volume at $21.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.240 between high and low, or 1.12%. For the last week the stock has had daily average volatility of 0.634%.

Our recommended stop-loss: $20.99 (-3.16%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 58 days ago.)

Trading Expectations (LABP) For The Upcoming Trading Day Of Thursday 18th

For the upcoming trading day on Thursday, 18th we expect Landos Biopharma, Inc. to open at $21.61, and during the day (based on 14 day Average True Range), to move between $21.10 and $22.24, which gives a possible trading interval of +/-$0.573 (+/-2.64%) up or down from last closing price. If Landos Biopharma, Inc. takes out the full calculated possible swing range there will be an estimated 5.29% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $21.56, some $0.110 (0.51%) from the current price of $21.67, our system finds the risk reward attractive.

Is Landos Biopharma, Inc. stock A Buy?

Landos Biopharma, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.781 Strong Buy Candidate Upgraded

Predicted Opening Price for Landos Biopharma, Inc. of Thursday, April 18, 2024

Fair opening price April 18, 2024 Current price
$21.61 ( 0.277%) $21.67

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LABP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 21.85 0.83 %
R2 21.76 0.408 %
R1 21.70 0.146 %
Current price: 21.67
Support S1 21.52 -0.700 %
S2 21.46 -0.96 %
S3 21.37 -1.38 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 21.67
Support S1 21.56 -0.508%
S2 21.50 -0.784%
S3 21.40 -1.25%

FAQ

What is the symbol for Landos Biopharma, Inc. Stock and on which exchange is it traded?
The symbol for Landos Biopharma, Inc. is LABP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Landos Biopharma, Inc. Stock?
Landos Biopharma, Inc. holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy Landos Biopharma, Inc. Stock?
Landos Biopharma, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Landos Biopharma, Inc. Stock.

What's the current price of Landos Biopharma, Inc. Stock?
As of the end of day on the 2024-04-17, the price of an Landos Biopharma, Inc. (LABP) share was $21.67.

What is the 52-week high and low for Landos Biopharma, Inc. Stock?
The 52-week high for Landos Biopharma, Inc. Stock is $21.87 and the 52-week low is $0.260.

What is the market capitalization of Landos Biopharma, Inc. Stock?
As of the 2024-04-17, the market capitalization of Landos Biopharma, Inc. is 67.54M.

When is the next earnings date for Landos Biopharma, Inc.?
The upcoming earnings date for Landos Biopharma, Inc. is May 10, 2024.
Click to get the best stock tips daily for free!

About Landos Biopharma, Inc.

Landos Biopharma. Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. The company's lead product candidate in development include omilancor, a gut-restricted oral therapeutic candidate that targets lanthionine synthetase C-like protein 2 (LANCL2) for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and eosinophilic esophagitis; NX-13, a gut-restricted ora... LABP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT